Anastrozole for advanced breast cancer
is a topic covered in the Evidence-Based Medicine Guidelines
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
"Anastrozole for Advanced Breast Cancer." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451175/all/Anastrozole_for_advanced_breast_cancer.
Anastrozole for advanced breast cancer. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/451175/all/Anastrozole_for_advanced_breast_cancer. Accessed March 24, 2019.
Anastrozole for advanced breast cancer. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/451175/all/Anastrozole_for_advanced_breast_cancer
Anastrozole for Advanced Breast Cancer [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 March 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451175/all/Anastrozole_for_advanced_breast_cancer.
TY - ELEC
T1 - Anastrozole for advanced breast cancer
ID - 451175
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451175/all/Anastrozole_for_advanced_breast_cancer
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine